3 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...
Healio7d
Although superior to other insulin therapies, hybrid closed-loop systems differ in efficacy
Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...
Medtronic Hires CFO From Renault
Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...
drugdeliverybusiness12d
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.